FLJ Visseren

Type de document

Articles (3)

Co-auteur

Date

Source

Mot-clé

thérapie (3) risque (3) maladie cardiovasculaire (3) Treatment (3) Therapeutics (3) Risk (3) évaluation du risque (2) gestion (2) lipide (2) Europe (2) âge (2) classification (2) Europe (2) Control (2) Care (2) Prevention (2) Risk assessment (2) Patients (2) Manufacturers' agents (2) Management (2) Evaluation (2) Europe (2) Commission merchants (2) Classification (2) Cholesterol (2) Age (2) Classification (2) Classification (2) Management (2) Age (2)

Documents écrit par FLJ Visseren (3) | parle de FLJ Visseren (0)

Comparison of the European and US guidelines for lipid-lowering therapy in primary prevention of cardiovascular disease.
B. Delabays et al. (30 nov. 2023)
Treatment gaps in the implementation of LDL cholesterol control among high- and very high-risk patients in Europe between 2020 and 2021: the multinational observational SANTORINI study.
K.K. Ray et al.
Evaluation of contemporary treatment of high- and very high-risk patients for the prevention of cardiovascular events in Europe - Methodology and rationale for the multinational observational SANTORINI study.
K.K. Ray et al.